Sie sind hier: UHH > Chemie > Institute und Abteilungen > Biochemie und Molekularbiologie > Publikationen > Kerstin David
Inhalt:
Kurzbiographie
| 1960 | geboren in Hamburg |
| 1996 | Promotion bei Carl-Wilhelm in Hamburg |
| 1997-1999 | Wissenschaftliche Angestellte (C1), Fachbereich Chemie der Universität Hamburg, Abteilung für Biochemie und Molekularbiologie |
| 1999-2001 | Assistant Professor, Cancer Research Center of Hawaii, University of Hawaii at Manoa, USA |
| 2001-2003 | Arbeitsgruppenleiterin (C1), Fachbereich Chemie der Universität Hamburg, Abteilung für Abteilung für Biochemie und Molekularbiologie |
| 2002 | Habilitation in Hamburg |
| 2002- | Leitung Labor, Forschung und Service (Vice President Research & Services) der Indivumed GmbH, Hamburg |
| 2003- | Privatdozentin für Biochemie und Molekularbiologie an der Universität Hamburg |
Weitere Informationen
Publikationen
2008 | |
| 1 |
Sample preparation by laser microdissection and catapulting for proteome analysis Karin Schütze; Andrea Buchstaller; Yilmaz Niyaz; Christian Melle; Günther Ernst; Kerstin A. David; Thorsten Schlomm; Ferdinand von Eggeling -/- Herausgeber: Jörg von Hagen Proteomics Sample Preparation 219-234 (2008) |
2007 | |
| 2 |
Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels Anne-Kristin Fentz; Monika Spörl; Jörg Spangenberg; Heinz Joachim List; Carsten Zornig; Arnulf Dörner; Peter Layer; Hartmut Juhl; Kerstin A. David Proteomics: Clinical Applications 1, 536-544 (2007) |
| 3 |
Use of endoplasmin fragment as a biomarker for colorectal adenoma and/or carcinoma Hartmut Juhl; Kerstin A. David; Anne-Kristin Fentz Patent: WO 2007019875 (A1) 2007-02-22 |
| 4 |
Use of c3a and derivatives thereof as a biomarker for benign lung tissue alterations and malignant lung tumors, method for detection and test system Hartmut Juhl; Kerstin A. David Patent: WO 2007065463 (A1) 2007-06-14 |
2006 | |
| 5 |
Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system Hartmut Juhl; Kerstin A. David Patent: WO 2006015616 (A1) 2006-02-16 |
| 6 |
Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same Hartmut Juhl; Kerstin A. David; Anne-Kristin Fentz Patent: WO 2006053592 (A1) 2006-05-26 |
2005 | |
| 7 |
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis Thorsten Schlomm; Andreas M. Luebke; Holger Sültmann; Olaf J. C. Hellwinkel; Ulrich Sauer; Annemarie Poustka; Kerstin A. David; Felix K. H. Chun; Alexander Haese; Markus Graefen; Andreas Erbersdobler; Hartwig Huland International Journal of Oncology 27, 713-720 (2005) |
| 8 |
Detection and quantification of mutations in the plasma of patients with colorectal tumors Frank Diehl; Meng Li; Devin Dressman; Yiping He; Dong Shen; Steve Szabo; Luis A. Diaz; Steven N. Goodman; Kerstin A. David; Hartmut Juhl; Kenneth W. Kinzler; Bert Vogelstein Proceedings of the National Academy of Sciences of the United States of America 102, 16368-16373 (2005) |
2004 | |
| 9 |
Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision Annika Sprüssel; Garnet Steimann; Mira Jung; Sung A. Lee; Theresa Carr; Anne-Kristin Fentz; Jörg Spangenberg; Carsten Zornig; Hartmut H. Juhl; Kerstin A. David BioTechniques 36, 1030-1037 (2004) |
2002 | |
| 10 |
Key role of mitochondria in cerulenin-mediated apoptosis Sven Heiligtag; Reinhard Bredehorst; Kerstin A. David Cell Death and Differentiation 9, 1017-1025 (2002) |
| 11 |
Identifizierung und Charakterisierung von Apoptose-induzierenden Wirkstoffen zur Behandlung des Neuroblastom Kerstin A. David Habilitationsschrift, Hamburg (2002) |
2001 | |
| 12 |
A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies Sylvia Engler; Christian Thiel; Kristine Förster; Kerstin A. David; Reinhard Bredehorst; Hartmut Juhl Cancer Research 61, 2968-2973 (2001) |
| 13 |
What establishes a protein as an allergen? Reinhard Bredehorst; Kerstin A. David Journal of Chromatography, B: Biomedical Sciences and Applications 756, 33-40 (2001) |
| 14 |
Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM Kerstin A. David; Sven Heiligtag; Markus W. Ollert; M. Teppke; Carl-Wilhelm Vogel; Reinhard Bredehorst Medical and Pediatric Oncology 36, 251-257 (2001) |
1999 | |
| 15 |
Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen Kerstin A. David; Markus W. Ollert; Caren Vollmert; Sven Heiligtag; Britta Eickhoff; Rudolf Erttmann; Reinhard Bredehorst; Carl-Wilhelm Vogel Cancer Research 59, 3768-3775 (1999) |
| 16 |
Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial Caroline Schmitt; Kerstin A. David; J. Hiller; J. Schrum; Reinhard Bredehorst; Carl-Wilhelm Vogel; C. Löliger; Rudolf Erttmann Klinische Pädiatrie 211, 314-318 (1999) |
1997 | |
| 17 |
Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid Kerstin A. David; A. Ehrhardt; Markus W. Ollert; Rudolf Erttmann; Reinhard Bredehorst; Carl-Wilhelm Vogel European Journal of Cancer 33, 1937-1941 (1997) |
| 18 |
Mechanisms of in vivo antineuroblastoma activity of human natural IgM Markus W. Ollert; Kerstin A. David; C. Vollmert; Hartmut Juhl; Rudolf Erttmann; Reinhard Bredehorst; Carl-Wilhelm Vogel European Journal of Cancer 33, 1942-1948 (1997) |
1996 | |
| 19 |
Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans Kerstin A. David; Markus W. Ollert; Hartmut Juhl; Caren Vollmert; Rudolf Erttmann; Carl-Wilhelm Vogel; Reinhard Bredehorst Nature Medicine 2, 686-689 (1996) |
| 20 |
Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients Rudolf Erttmann; Caroline Schmitt; Markus W. Ollert; Kerstin A. David; Reinhard Bredehorst; Carl-Wilhelm Vogel Pediatric Hematology and Oncology 13, 545-548 (1996) |
| 21 |
Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells Markus W. Ollert; Kerstin A. David; Caroline Schmitt; Alexander Hauenschild; Reinhard Bredehorst; Rudolf Erttmann; Carl-Wilhelm Vogel Proceedings of the National Academy of Sciences of the United States of America 93, 4498-4503 (1996) |
| 22 |
Natürliche zytotoxische Antikörper gegen humane Neuroblastom-Zellen : Analyse der zytotoxischen Mechanismen und Charakterisierung des Antigens Kerstin A. David (= Kerstin David) -/- Betreuer: Carl-Wilhelm Vogel Dissertation, Hamburg (1996), ISBN 978-3-928943-89-5; 3-928943-89-8, Verlag: Wissenschaft und Technik Verl. Groß, Berlin |
1995 | |
| 23 |
Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b Markus W. Ollert; Kerstin A. David; Reinhard Bredehorst; Carl-Wilhelm Vogel Journal of Immunology 155, 4955-4962 (1995) |
1994 | |
| 24 |
Antibody-mediated complement activation on nucleated cells Markus W. Ollert; Joseph V. Kadlec; Kerstin A. David; Eugene C. Petrella; Reinhard Bredehorst; Carl-Wilhelm Vogel Journal of Immunology 153, 2213-2221 (1994) |
